- Phase I
- Phase II/III
- Therapeutic expertise
- Rescue services
- Technology solutions
- Comprehensive capabilities
- News &
How can customers benefit from Rho's balanced business model?
Rho's business model strengthens our services offerings
Rho has created a strong presence in the federal CRO market through our direct support of numerous National Institutes of Health (NIH) studies, as well as our participation on various NIH panels. The mutually beneficial combination of our federal and commercial services has enabled Rho to attract and retain some of the brightest minds in clinical research, beginning with our Principal Investigators.
Rho's commercial operations professionals regularly work in tandem with our Principal Investigators who are conducting federally sponsored research. This collaborative culture benefits each group, as key staff members work across project platforms, bolstering their professional development and expertise. This helps members of both federal and commercial projects develop a greater understanding of all aspects of trials, enabling them to adapt to any study or situation and to contribute at any point to the clinical research process.
Rho's federal work also enables our staff to provide service to their profession in addition to their project work. This is evident in the 100+ peer-reviewed publications, presentations, and speaking occasions our staff members participate in each year.
Our customers refer to us as the "thinkingest CRO" because the breadth and depth of our commercial and federal experience strengthens our expertise and knowledge.